Diskussionsleitung: P. Bengel (Göttingen), S. Neef (Regensburg)
| (P463) | Divergent safety profile of the SGLT2 inhibitors dapagliflozin and empagliflozin in a whole-heart model | |
| C. Ellermann, J. Uphoff, J. Wolfes, H. Könemann, B. Rath, P. Leitz, L. Eckardt, G. Frommeyer (Münster) | ||
| (P464) | Alpha-1 adrenoceptor and small calcium-activated potassium channel contribute to endothelial dysfunctions caused by catecholamine excess | |
| Z. Yang, Y. Li, X. Fan, Z. Meng, L. Qiao, M. Huang, I. El-Battrawy, X. Zhou, I. Akin (Mannheim) | ||
| (P465) | Autophagy is involved in the pathomechanism of Brugada syndrome | |
| Y. Li, H. Dinkel, D. Pakalniskyte, L. Cyganek, R. Zhong, F. Zhang, L. Maywald, A. Aweimer, A. Hohn, I. Akin, X. Zhou, I. El-Battrawy (Mannheim, Göttingen, Bochum) | ||
| (P466) | Empagliflozin verbessert die kardiale Funktion im Modell der Adenin-induzierter urämischen Kardiomyopathie | |
| J. Möllmann, B. M. Klinkhammer, P. Boor, N. Marx, M. Lehrke (Aachen) | ||
| (P467) | Dexamethasone increases the L-type Ca2+ current in human ventricular cardiomyocytes | |
| B. Pfeilschifter, A. Ritzer, S. Sommer, V. Baron, D. Fiegle, C. Heim, M. Weyand, H. Milting, T. Seidel, T. Volk (Erlangen, Bad Oeynhausen) | ||
| (P468) | Ion Channel Expression and Characterization in Human Induced Pluripotent Stem Cell-Derived endothelial cells | |
| X. Fan, L. Cyganek, Z. Yang, K. Bieback, I. El-Battrawy, X. Zhou, I. Akin (Mannheim, Göttingen) | ||
| (P469) | Nuclear Ca2+-Calmodulin signaling controls catecholamine-evoked hypertrophy in cardiomyocytes via control of the protein translation | |
| A. Riedel, R. Medert, S. Monaco, X. Tolksdorf, C. Richter, M. Schrader, V. Kuryshev, M. Busch, A. Jungmann, E. Gjerga, A. Wirth, V. Benes, C. Dieterich, P. Most, M. Völkers, H. Bading, M. Freichel, für die Studiengruppe: DZHK (Heidelberg) |
